Emmes Acquires Essex Management
March 21, 2023
Emmes, a global full-service clinical research organization, acquired Essex Management, a bioinformatics and health information technology consultancy, to enhance Emmes' data, bioinformatics and HIT capabilities. The acquisition adds more than 100 employees and expands Emmes' ability to serve government, academic and biopharma clients, including continued support for the National Cancer Institute.
- Buyers
- Emmes
- Targets
- Essex Management
- Industry
- Healthcare Services
- Location
- Maryland, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
New Mountain Capital Acquires Emmes from Behrman Capital
June 21, 2022
Healthcare Services
Affiliates of New Mountain Capital have agreed to acquire Emmes, a global clinical research organization, from Behrman Capital and Emmes' other investors. The transaction, expected to close in early July 2022, positions Emmes for its next phase of growth with additional investment to expand its commercial, global and eClinical technology capabilities; terms were not disclosed.
-
Behrman Capital Invests in The Emmes Corporation
March 11, 2019
Healthcare Services
Behrman Capital, a private equity firm, made a significant investment in The Emmes Corporation, a Rockville, Maryland–based contract research organization (CRO). Management will remain in place and Sal Guccione joined as Executive Chairman; Behrman said the investment will support growth—including expanding non‑government business, global presence, and accretive acquisitions.
-
Emmes Acquires Clinical Edge
September 28, 2022
Healthcare Services
Emmes, a global full-service clinical research organization, has acquired Clinical Edge, a Milwaukee-based provider of visual function examiner training and certification for ophthalmic clinical trials. The deal combines Clinical Edge with Emmes' Optym ophthalmology unit (rebranded OptymEdge), expanding Emmes' ophthalmology certification capabilities and geographic reach across the U.S., Europe and Asia.
-
Emmes Acquires Institut Dr. Schauerte
December 21, 2021
Healthcare Services
Emmes, a Behrman Capital portfolio company, has acquired Institut Dr. Schauerte (IDS), a Munich- and Cottbus-based clinical research organization specializing in late-phase, non-interventional and post-market studies. The add-on expands Emmes' European footprint and Real World Evidence capabilities; with IDS the Emmes organization surpasses 1,200 employees.
-
Emmes Acquires UK-Based Orphan Reach
May 11, 2021
Healthcare Services
Emmes, a global full-service CRO and portfolio company of Behrman Capital, acquired Orphan Reach, a UK-based CRO specialized in rare-disease clinical research. The add-on expands Emmes' geographic footprint and rare-disease capabilities; Orphan Reach's founder and management will remain in place and financial terms were not disclosed.
-
Optum (UnitedHealth) Acquires EMIS Group plc
October 27, 2023
Healthcare Services
Bordeaux UK Holdings II Limited, an affiliate of Optum Health Solutions (UK) Limited and ultimately owned by UnitedHealth Group, has acquired EMIS Group plc. Optum UK said EMIS will remain based in Leeds with continuity of operations while receiving accelerated investment to expand its healthcare technology, interoperability and data analytics capabilities for the UK health system.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.